Skip to content
Screener

Precigen PGEN Total Cost of Revenue

Total Cost of Revenue at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$3.73B+10.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$100.7M+69.6%
Gilead Sciences logo
Gilead SciencesGILD
$1.58B+5.2%
Opko Health logo
Opko HealthOPK
$83.56M-22.2%
ALN
Alnylam PharmaceuticalsALNY
$298.26M+110%
Amgen logo
AmgenAMGN
$2.81B-6.6%

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$2.47B+358%
Enterprise value$2.56B+382%
P/S93.2×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsSold.

The source filing: Precigen’s 10-Q, filed August 13, 2018. Open the filing →

Filed
Aug 13, 2018
Fiscal quarter
Q2 FY2018
Calendar quarter
Q2 2018
Accession
0001356090-18-000012

FAQ

What does total cost of revenue mean?
The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.